ASX:PAA

PharmAust Competitors

Add

Compare

Today's Range N/A

50-Day Range

A$0.11

MA: A$0.11▼

A$0.11

52-Week Range N/A

Volume3.27 million shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

PharmAust (ASX:PAA) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying PAA stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to PharmAust, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

PharmAust vs. (CHV) Stock

PharmAust (ASX:PAA) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.

Valuation and Earnings

This table compares PharmAust and (CHV)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PharmAust	$4.12 million	0.00	$-1,583,649.92	A($0.01)	N/A
(CHV)	N/A	N/A	N/A	N/A	N/A

(CHV) has lower revenue, but higher earnings than PharmAust.

Profitability

This table compares PharmAust and (CHV)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PharmAust	N/A	N/A	N/A
(CHV)	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings for PharmAust and (CHV), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PharmAust	0	0	0	0	N/A
(CHV)	0	0	0	0	N/A

Summary

PharmAust beats (CHV) on 1 of the 1 factors compared between the two stocks.

PharmAust vs. (DDXS) Stock

PharmAust (ASX:PAA) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent recommendations for PharmAust and (DDXS), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PharmAust	0	0	0	0	N/A
(DDXS)	0	0	0	0	N/A

Earnings & Valuation

This table compares PharmAust and (DDXS)'s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PharmAust	$4.12 million	0.00	$-1,583,649.92	A($0.01)	N/A
(DDXS)	N/A	N/A	N/A	N/A	N/A

(DDXS) has lower revenue, but higher earnings than PharmAust.

Profitability

This table compares PharmAust and (DDXS)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PharmAust	N/A	N/A	N/A
(DDXS)	N/A	N/A	N/A

Summary

PharmAust beats (DDXS) on 1 of the 1 factors compared between the two stocks.

PharmAust vs. (PREV) Stock

PharmAust (ASX:PAA) and (PREV) (CNSX:PREV) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

Profitability

This table compares PharmAust and (PREV)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PharmAust	N/A	N/A	N/A
(PREV)	N/A	N/A	N/A

Valuation & Earnings

This table compares PharmAust and (PREV)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PharmAust	$4.12 million	0.00	$-1,583,649.92	A($0.01)	N/A
(PREV)	N/A	N/A	N/A	N/A	N/A

(PREV) has lower revenue, but higher earnings than PharmAust.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for PharmAust and (PREV), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PharmAust	0	0	0	0	N/A
(PREV)	0	0	0	0	N/A

Summary

PharmAust beats (PREV) on 1 of the 1 factors compared between the two stocks.

PharmAust vs. (TNGN) Stock

PharmAust (ASX:PAA) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends.

Analyst Ratings

This is a summary of current recommendations and price targets for PharmAust and (TNGN), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PharmAust	0	0	0	0	N/A
(TNGN)	0	0	0	0	N/A

Valuation & Earnings

This table compares PharmAust and (TNGN)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PharmAust	$4.12 million	0.00	$-1,583,649.92	A($0.01)	N/A
(TNGN)	N/A	N/A	N/A	N/A	N/A

(TNGN) has lower revenue, but higher earnings than PharmAust.

Profitability

This table compares PharmAust and (TNGN)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PharmAust	N/A	N/A	N/A
(TNGN)	N/A	N/A	N/A

Summary

PharmAust beats (TNGN) on 1 of the 1 factors compared between the two stocks.

PharmAust vs. 138267 (COM.TO) Stock

138267 (COM.TO) (TSE:COM) and PharmAust (ASX:PAA) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation.

Profitability

This table compares 138267 (COM.TO) and PharmAust's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
138267 (COM.TO)	N/A	N/A	N/A
PharmAust	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings for 138267 (COM.TO) and PharmAust, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
138267 (COM.TO)	0	0	0	0	N/A
PharmAust	0	0	0	0	N/A

Earnings and Valuation

This table compares 138267 (COM.TO) and PharmAust's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
138267 (COM.TO)	N/A	N/A	N/A	N/A	N/A
PharmAust	$4.12 million	0.00	$-1,583,649.92	A($0.01)	N/A

138267 (COM.TO) has higher earnings, but lower revenue than PharmAust.

Summary

PharmAust beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

PharmAust vs. 17031 Stock

PharmAust (ASX:PAA) and 17031 (CNSX:MYM) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Profitability

This table compares PharmAust and 17031's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PharmAust	N/A	N/A	N/A
17031	N/A	N/A	N/A

Valuation & Earnings

This table compares PharmAust and 17031's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PharmAust	$4.12 million	0.00	C$-1,583,649.92	A($0.01)	N/A
17031	N/A	N/A	N/A	N/A	N/A

17031 has lower revenue, but higher earnings than PharmAust.

Analyst Recommendations

This is a summary of current ratings and recommmendations for PharmAust and 17031, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PharmAust	0	0	0	0	N/A
17031	0	0	0	0	N/A

Summary

PharmAust beats 17031 on 1 of the 1 factors compared between the two stocks.